Invesco’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.28M | Buy |
154,112
+66,679
| +76% | +$975K | ﹤0.01% | 2487 |
|
|
2025
Q4 | $1.39M | Sell |
87,433
-17,637
| -17% | -$250K | ﹤0.01% | 2765 |
|
|
2025
Q3 | $1.16M | Sell |
105,070
-13,674
| -12% | -$149K | ﹤0.01% | 2864 |
|
|
2025
Q2 | $1.01M | Sell |
118,744
-3,331
| -3% | -$26.7K | ﹤0.01% | 2842 |
|
|
2025
Q1 | $981K | Sell |
122,075
-22,037
| -15% | -$179K | ﹤0.01% | 2837 |
|
|
2024
Q4 | $1.29M | Buy |
144,112
+1,421
| +1% | +$11.6K | ﹤0.01% | 2803 |
|
|
2024
Q3 | $1.05M | Sell |
142,691
-977
| -0.7% | -$6.06K | ﹤0.01% | 2886 |
|
|
2024
Q2 | $820K | Buy |
143,668
+2,613
| +2% | +$13.8K | ﹤0.01% | 3037 |
|
|
2024
Q1 | $707K | Sell |
141,055
-3,634
| -3% | -$24.7K | ﹤0.01% | 3166 |
|
|
2023
Q4 | $1.3M | Buy |
144,689
+9,751
| +7% | +$80.3K | ﹤0.01% | 2780 |
|
|
2023
Q3 | $1.05M | Buy |
134,938
+8,511
| +7% | +$83.2K | ﹤0.01% | 2839 |
|
|
2023
Q2 | $1.22M | Sell |
126,427
-284
| -0.2% | -$2.95K | ﹤0.01% | 2812 |
|
|
2023
Q1 | $1.39M | Buy |
126,711
+44,128
| +53% | +$389K | ﹤0.01% | 2776 |
|
|
2022
Q4 | $357K | Sell |
82,583
-5,868
| -7% | -$34K | ﹤0.01% | 3436 |
|
|
2022
Q3 | $665K | Buy |
88,451
+1,985
| +2% | +$17.2K | ﹤0.01% | 3093 |
|
|
2022
Q2 | $868K | Buy |
86,466
+53,715
| +164% | +$600K | ﹤0.01% | 3042 |
|
|
2022
Q1 | $405K | Buy |
32,751
+21,340
| +187% | +$330K | ﹤0.01% | 3498 |
|
|
2021
Q4 | $261K | Sell |
11,411
-3,218
| -22% | -$76.3K | ﹤0.01% | 3672 |
|
|
2021
Q3 | $324K | Sell |
14,629
-3,342
| -19% | -$53K | ﹤0.01% | 3625 |
|
|
2021
Q2 | $233K | Buy |
+17,971
| New | +$229K | ﹤0.01% | 3733 |
|
|
2018
Q1 | – | Sell |
-10,578
| Closed | -$48K | – | 3714 |
|
|
2017
Q4 | $48K | Buy |
+10,578
| New | +$58.7K | ﹤0.01% | 3632 |
|
Other funds holding AUPH
TCM
NMC
